Later studies implied that cell sensitivity to allosteric Akt1/2 inhibitors is significantly associated with Akt phosphorylation in human cancer cell lines, leading to the conclusion that cell lines with elevated levels of phosphorylated Akt are more susceptible to the pharmacologic inhibition of Akt1/2. Here, AKT1 is linked to cancer.